Evidence map›Paper›PMID 27186310›Full record

ArticleAmerican journal of translational research2016

Phenylbutyrate prevents disruption of blood-spinal cord barrier by inhibiting endoplasmic reticulum stress after spinal cord injury.

Yulong Zhou, Libing Ye, Binbin Zheng, Sipin Zhu, Hongxue Shi, Hongyu Zhang, Zhouguang Wang, Xiaojie Wei, Daqing Chen, Xiaokun Li and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Barrier function in the peripheral and central nervous system-a review.Pflugers Archiv : European journal of physiology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yulong ZhouDepartment of Orthopaedics, The Second Affiliated Hospital, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China; Molecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China.
Libing YeMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Binbin ZhengDepartment of Orthopaedics, The Second Affiliated Hospital, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China; Molecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China.
Sipin ZhuDepartment of Orthopaedics, The Second Affiliated Hospital, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China; Molecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical UniversityWenzhou, Zhejiang 325035, China.
Hongxue ShiMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Hongyu ZhangMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Zhouguang WangMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Xiaojie WeiDepartment of Neurosurgery, Cixi People's Hospital, Wenzhou Medical University Ningbo 315300, China.
Daqing ChenDepartment of Emergency, The Second Affiliated Hospital Hospital, Wenzhou Medical University Wenzhou 325035, China.
Xiaokun LiMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Huazi XuDepartment of Orthopaedics, The Second Affiliated Hospital, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Jian XiaoMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou, Zhejiang 325035, China.
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate the role of endocytoplasmic reticulum (ER) stress induced by spinal cord injury (SCI) in blood-spinal cord barrier (BSCB) disruption and the effect of phenylbutyrate (PBA) on BSCB disruption after SCI. After a moderate contusion injury at the T9 level of spinal cord with a vascular clip, PBA was immediately administered into injured rat via intraperitoneal injection (100 mg/kg) and then further treated once a day for 2 weeks for behavior test. Spinal cord was collected at 1 day post-injury for evaluation of the effects of ER stress and PBA on BSCB disruption after SCI. PBA significantly attenuated BSCB permeability and degradation of tight junction molecules such as P120, β-catenin, Occludin and Claudin5 at 1 day after injury and improved functional recovery in the rat model of trauma. The BSCB protective effect of PBA is related to the inhibition of ER stress induced by SCI. In addition, PBA significantly inhibited the increase of ER stress markers and prevents loss of tight junction and adherens junction proteins in TG-treated human brain microvascular endothelial cells (HBMEC). Taken together, our data demonstrate that therapeutic strategies targeting ER stress may be suitable for the therapy of preserving BSCB integrity after SCI. PBA may be a new candidate as a therapeutic agent for protecting SCI by a compromised BSCB.

Indexed as

Blood-spinal cord barrierER stressphenylbutyratespinal cord injury

Identifiers

PMID27186310
PMCPMC4859915
OpenAlexW2403923637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.